Literature DB >> 27349448

Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery.

Alessandra C Pinheiro, Thais C Mendonça Nogueira, Marcus V N de Souza1.   

Abstract

Heterocyclic compounds are a class of substances, which play a critical role in modern drug discovery being incorporated in the structure of a large variety of drugs used in many different types of diseases. Quinoxaline is an important heterocyclic nucleus with a wide spectrum of biological activities, and recently much attention has been found on anticancer drug discovery based on this class. Owing to the importance of this system, the aim of this review is to provide an update on the synthesis and anticancer activity of quinoxaline derivatives covering articles published between 2010 and 2015.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27349448     DOI: 10.2174/1871520616666160622090839

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  6 in total

1.  Synthesis of Morpholine-, Piperidine-, and N-Substituted Piperazine-Coupled 2-(Benzimidazol-2-yl)-3-arylquinoxalines as Novel Potent Antitumor Agents.

Authors:  Vakhid A Mamedov; Nataliya A Zhukova; Alexandra D Voloshina; Victor V Syakaev; Tat'yana N Beschastnova; Anna P Lyubina; Syumbelya K Amerhanova; Aida I Samigullina; Aidar T Gubaidullin; Daina N Buzyurova; Il Dar Kh Rizvanov; Oleg G Sinyashin
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-01

2.  Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling.

Authors:  Hatem A Abdel-Aziz; Wagdy M Eldehna; Adam B Keeton; Gary A Piazza; Adnan A Kadi; Mohamed W Attwa; Ali S Abdelhameed; Mohamed I Attia
Journal:  Drug Des Devel Ther       Date:  2017-08-09       Impact factor: 4.162

3.  Spectral Probe for Electron Transfer and Addition Reactions of Azide Radicals with Substituted Quinoxalin-2-Ones in Aqueous Solutions.

Authors:  Konrad Skotnicki; Slawomir Ostrowski; Jan Cz Dobrowolski; Julio R De la Fuente; Alvaro Cañete; Krzysztof Bobrowski
Journal:  Int J Mol Sci       Date:  2021-01-10       Impact factor: 5.923

Review 4.  Recent advances in the transition-metal-free synthesis of quinoxalines.

Authors:  Biplob Borah; L Raju Chowhan
Journal:  RSC Adv       Date:  2021-11-19       Impact factor: 4.036

5.  Design and synthesis of new bis(1,2,4-triazolo[3,4-b][1,3,4]thiadiazines) and bis((quinoxalin-2-yl)phenoxy)alkanes as anti-breast cancer agents through dual PARP-1 and EGFR targets inhibition.

Authors:  Fatma M Thabet; Kamal M Dawood; Eman A Ragab; Mohamed S Nafie; Ashraf A Abbas
Journal:  RSC Adv       Date:  2022-08-19       Impact factor: 4.036

6.  Synthesis and cytotoxic evaluation of novel quinazolinone derivatives as potential anticancer agents.

Authors:  Safoora Poorirani; Sedighe Sadeghian-Rizi; Ghadamali Khodarahmi; Marzieh Rahmani Khajouei; Farshid Hassanzadeh
Journal:  Res Pharm Sci       Date:  2018-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.